2026-IdrDip-07-medmol - Hereditary Hemorrhagic Telangiectasia (HHT): variant discovery and development of therapeutic strategies
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
pOrganisation/Company Università di Pavia Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 25 Nov 2026
- 12:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No /ph3Offer Description /h3pRescue Genome analysis in patients without a molecular diagnosis following a conventional diagnostic workup.
The role will involve: analysis of sequencing results, identification and classification of cryptic variants, and characterisation of variants, with a specific focus on those associated with splicing alterations. Secondary analyses via RNA-seq on patient biopsies to identify altered pathways in the disease. Finally, development of RNA-targeted therapeutic approaches aimed at rescuing the identified defect in patients /ppThe public call with detailed attendance and selection rules (Art 4 and 6) can be found at: selections are open to candidates, Italian or foreigner, in possession, on the date of the deadline for submitting applications for the admission to the selection, of a master's degree or single-cycle, degree obtained no more than six years previously are eligible to participate in the selection process. These degrees must be relevant to the subject of the research activity.br/Further specific assessable qualifications (see Art. 1 par. 1 Call for applications):br/A PhD in subjects relevant to the Academic Disciplines of the position (Bios-10A/Meds-01A), as well as previous experience in molecular biology techniques and cell culture, will be considered an advantage /pulliAFRICA /liliEUROPE /liliOCEANIA /liliNORTH AMERICA /liliSOUTH AMERICA /liliASIA /liliOTHER /li /ulpbEligibility of fellows: country/ies of residence: /b /pulliAFRICA /liliEUROPE /liliOCEANIA /liliNORTH AMERICA /liliSOUTH AMERICA /liliASIA /liliOTHER /li /ulpbEligibility of fellows: nationality/ies: /b /pulliAFRICA /liliEUROPE /liliOCEANIA /liliNORTH AMERICA /liliSOUTH AMERICA /liliASIA /liliOTHER /li /ulh3Selection process /h3pThe application for admission to the selection procedure (dated and signed),the documents and publications considered useful for the evaluation must be submitted, under penalty of exclusion, electronically, by visiting the following web page: selecting the Competition Notice you have chosen. In order to register with the system, you must have an email address. Following the guidelines published in the procedure, the applicant must enter all the information required for the application, enclosing all documents in electronic .
PDF format. The selection of candidates is carried out on the basis of qualifications and possible interview (with test of knowledge of the foreign language) (see Art. 1 par. 1 Call for applications). /p #J-18808-Ljbffr